Medicaid expansion and restriction policies for hepatitis C treatment

NW Furukawa, SZ Ingber, H Symum… - JAMA Network …, 2024 - jamanetwork.com
Importance Hepatitis C can be cured with direct-acting antivirals (DAAs), but Medicaid
programs have implemented fibrosis, sobriety, and prescriber restrictions to control costs …

[HTML][HTML] Review of the Effects of Antiviral Therapy on Hepatitis B/C-Related Mortality and the Regression of Fibrosis

S Sinclair III, S Shearen, Y Ghobrial, G Trad, SA Basit… - …, 2024 - pmc.ncbi.nlm.nih.gov
Hepatitis B and Hepatitis C are viral causes of Hepatitis that lead to significant worldwide
mortality and morbidity through the sequelae of fibrosis and hepatocellular carcinoma. In this …

Disengagement from Care Among People Co-Infected with HIV and HCV: A Scoping Review

DA Dinh, Y Tan, S Saeed - AIDS and Behavior, 2024 - Springer
Disengagement from care among people with HIV (PWH) and hepatitis C (HCV) increases
the risks of adverse health outcomes and poses significant barriers to achieving global HIV …

Viral eradication reduces all‐cause mortality in patients with chronic hepatitis C virus infection who had received direct‐acting antiviral therapy

T Tada, M Kurosaki, H Toyoda, N Tamaki… - Liver …, 2024 - Wiley Online Library
Abstract Background and Aims The impact of hepatitis C virus (HCV) eradication via direct‐
acting antiviral (DAA) therapy on overall mortality, particularly non‐liver‐related mortality, is …

Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct …

AC Hearps, N Vootukuru… - Frontiers in …, 2024 - frontiersin.org
Background Hepatitis C virus (HCV) infections are more prevalent in people who inject
drugs (PWID) who often experience additional health risks. HCV induces inflammation and …

Effect of direct-acting antivirals on disease burden of hepatitis C virus infection in South Korea in 2007–2021: a nationwide, multicentre, retrospective cohort study

W Sohn, SY Park, TH Lee, YE Chon, IH Kim… - …, 2024 - thelancet.com
Background It is unclear whether direct-acting antivirals (DAAs) treatment improves the
disease burden in hepatitis C virus (HCV) infection. This study aimed to investigate the effect …

Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia

S Tillakeratne, SA Pearson, M Alavi… - The Lancet Regional …, 2024 - thelancet.com
Background Monitoring hepatitis B virus (HBV) and hepatitis C virus (HCV) liver-related
morbidity and mortality is key to evaluate progress towards elimination targets. Methods …

US Veterans Health Administration Hepatitis C Virus (HCV) Program: A Model for National HCV Elimination Through Patient-Centered Medical Homes

AH Litwin, MJ Akiyama - Clinical Infectious Diseases, 2024 - academic.oup.com
The article by Varley et al published in this issue of Clinical Infectious Diseases is a
landmark study that highlights the effectiveness of a national hepatitis C virus (HCV) …

Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After Hepatitis C Cure (ANRS CO22 Hepather)

T Barré, L Parlati, M Bourlière, C Ramier… - Journal of viral …, 2024 - Wiley Online Library
ABSTRACT Although Hepatitis C virus (HCV) infection can be cured with direct‐acting
antivirals (DAA), some cured patients face a serious risk of advanced liver damage and early …

[HTML][HTML] Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C …

H Karimi-Sari, GM Lucas, K Zook, B Weir, M Landry… - Viruses, 2024 - mdpi.com
Background: Hepatitis C virus (HCV) infection and hazardous alcohol use are both
preventable causes of morbidity and mortality among people who inject drugs (PWID). In the …